Journals / Selcuk Dental Journal / 2021 / Cilt: 8 - Sayı: 3

The Relationship Between Plasma MicroRNAs and Serum Mercury Levels in Patients with Amalgam Filling and Dentists

Amalgam Dolgulu Hastalarda ve Diş Hekimlerinde Plazma MikroRNA'lar ile Serum Civa Düzeyleri Arasındaki İlişki

Pages
736–743
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Alternative restorative materials should be preferred for amalgam filling and amalgam fillings should be replaced with other restorative materials under necessary preventions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of this study was to investigate the relationship between serum mercury and some plasma microRNA (miRNA) levels associated with neurological diseases in patients with amalgam filling and dentists.
📊
Key Findings & Data:Methods: This study included 30 patients with amalgam filling, 30 dentists, and 30 healthy individuals as the control group.
💡
Conclusion & Impact:Alternative restorative materials should be preferred for amalgam filling and amalgam fillings should be replaced with other restorative materials under necessary preventions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Dental amalgam · civa · restoratif materyal

Abstract

Background: The aim of this study was to investigate the relationship between serum mercury and some plasma microRNA (miRNA) levels associated with neurological diseases in patients with amalgam filling and dentists. Methods: This study included 30 patients with amalgam filling, 30 dentists, and 30 healthy individuals as the control group. Circulating plasma miRNAs (124-3p, 125-5p, and 127-3p) were evaluated using real-time quantitative polymerase chain reaction analysis. The serum mercury levels were measured using inductively coupled plasma-mass spectrometry. ANOVA and Tukey’s multiple comparison tests were used for statistical analyses (α =.05). Results: A significant difference in serum mercury and plasma miRNA levels was found between the groups. Significant positive correlations between serum mercury and plasma miRNA 125-5p and 127-3p levels were detected in the patient group (r: 0.56 and r: 0.39, respectively). Serum mercury and plasma miRNA-125-5p levels showed a positive correlation in the dentist group (r: 0.37). Conclusion: Having amalgam filling caused a significant increase in serum mercury and plasma miRNA levels. The presence of a positive correlation suggests that sensitivity to neurological diseases may increase because of mercury exposure. Alternative restorative materials should be preferred for amalgam filling and amalgam fillings should be replaced with other restorative materials under necessary preventions.

Özet

Amaç: Bu çalışmanın amacı, amalgam dolgusu olan hastalarda ve diş hekimlerinde serum civa ve nörolojik hastalıklarla ilişkili bazı plazma mikroRNA (miRNA) seviyeleri arasındaki ilişkiyi araştırmaktır. Gereç ve Yöntemler: Bu çalışmaya 30 amalgam dolgulu hasta, 30 diş hekimi ve 30 sağlıklı kontrol grubu dahil edildi. Dolaşımdaki plazma miRNA'lar (124-3p, 125-5p ve 127-3p), gerçek zamanlı kantitatif polimeraz zincir reaksiyonu analizi kullanılarak değerlendirildi. Serum civa seviyeleri, endüktif olarak eşleşmiş plazma-kütle spektrometresi kullanılarak ölçüldü. İstatistiksel analizler için ANOVA ve Tukey’in çoklu karşılaştırma testleri kullanıldı (α = .05). Bulgular: Gruplar arasında serum civa ve plazma miRNA seviyelerinde anlamlı bir fark bulundu. Hasta grubunda serum civa ile plazma miRNA 125-5p ve 127-3p seviyeleri arasında anlamlı pozitif korelasyonlar tespit edildi (sırasıyla r: 0.56 ve r: 0.39). Serum civa ve plazma miRNA-125-5p seviyeleri, diş hekimi grubunda pozitif bir korelasyon gösterdi (r: 0.37). Sonuç: Amalgam dolguya sahip olmak serum civa ve plazma miRNA düzeylerinde önemli bir artışa neden olmuştur. Pozitif bir korelasyonun varlığı, civa maruziyeti nedeniyle nörolojik hastalıklara duyarlılığın artabileceğini göstermektedir. Amalgam dolgu için alternatif restoratif materyaller tercih edilmeli ve amalgam dolgular, gerekli önlemler alınarak diğer restoratif materyaller ile değiştirilmelidir.

🔖

Cite This Article

TUNÇDEMİR, M. T., OMEZLİ, M. M. (2021). The Relationship Between Plasma MicroRNAs and Serum Mercury Levels in Patients with Amalgam Filling and Dentists. Selcuk Dental Journal, Cilt: 8 - Sayı: 3, 736–743. https://ajindex.com/articles/406859

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Referans 1. Chin G, Chong J, Kluczewska A, Lau A, Gorjy S. The environmental effects of dental amalgam. Aust Dent J 2000
  2. Referans 2. Counter SA, Buchanan LH. Mercury exposure in children: a review. Toxicol Appl Pharmacol 2004
  3. Referans 3. Berlin M, Zalups RK, Fowler BA. Mercury. In: Nordberg G, Fowler RA, Nordberg M, Friberg LT (eds). Handbook on the toxicology of metals. 3rd ed. Burlington: Academic Press, 2007. Referans 4. Langan DC, Fan PL, Hoos AA. The use of mercury in dentistry: a critical review of the recent literature. J Am Dent Assoc 1987
  4. Referans 5. Yip HK, Li DK, Yau DC. Dental amalgam and human health. Int Dent J 2003
  5. Referans 6. Godfrey ME, Wojcik DP, Krone CA. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. J Alzheimers Dis 2003
  6. Referans 7. Langworth S, Bjorkman L, Elinder CG, JärupL, Savlin P. Multidisciplinary examination of patients with illness attributed to dental fillings. J Oral Rehabil 2002
  7. Referans 8. Hock C, Drasch G, Golombowski S, Müller-Spahn F, Willershausen-Zönnchen B, Schwarz P, et al. Increased blood mercury levels in patients with Alzheimer's Disease. J Neural Transm 1998
  8. Referans 9. Bjørklund G, Hilt B, Dadar M, Lindh U, Aaseth J. Neurotoxic effects of mercury exposure in dental personnel. Basic Clin Pharmacol Toxicol 2019
  9. Referans 10. Bilen J, Liu N, Bonini NM. A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins. Cell Cycle 2006
  10. 2835–8. Referans 11. Johnson R, Noble W, Tartaglia GG, Buckley NJ. Neurodegeneration as an RNA disorder. Prog Neurobiol 2012
  11. 293–315. Referans 12. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002
  12. 735–9. Referans 13. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. A microRNA array reveals extensive regulation of micro-RNAs during brain development. RNA 2003
  13. 1274–81. Referans 14. Miska EA, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P, et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 2004
  14. R68. Referans 15. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative premRNA splicing. Mol Cell 2007
  15. 435–48. Referans 16. Le MT, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J, et al